Lisanti Capital Growth’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-12,505
| Closed | -$361K | – | 113 |
|
|
2024
Q3 | $361K | Sell |
12,505
-12,380
| -50% | -$357K | 0.09% | 116 |
|
|
2024
Q2 | $955K | Sell |
24,885
-64,325
| -72% | -$2.47M | 0.23% | 103 |
|
|
2024
Q1 | $5.24M | Buy |
89,210
+42,905
| +93% | +$2.52M | 1.28% | 25 |
|
|
2023
Q4 | $2.77M | Sell |
46,305
-64,695
| -58% | -$3.87M | 0.65% | 68 |
|
|
2023
Q3 | $4.22M | Buy |
111,000
+65,505
| +144% | +$2.49M | 0.67% | 63 |
|
|
2023
Q2 | $4.14M | Sell |
45,495
-40,015
| -47% | -$3.65M | 0.57% | 79 |
|
|
2023
Q1 | $5.64M | Buy |
85,510
+29,815
| +54% | +$1.97M | 0.79% | 56 |
|
|
2022
Q4 | $2.88M | Sell |
55,695
-141,595
| -72% | -$7.32M | 0.39% | 93 |
|
|
2022
Q3 | $13.5M | Buy |
197,290
+67,782
| +52% | +$4.63M | 1.8% | 12 |
|
|
2022
Q2 | $5.86M | Buy |
129,508
+79,468
| +159% | +$3.59M | 0.8% | 55 |
|
|
2022
Q1 | $2.54M | Sell |
50,040
-53,385
| -52% | -$2.71M | 0.29% | 107 |
|
|
2021
Q4 | $4.89M | Buy |
+103,425
| New | +$4.89M | 0.71% | 65 |
|
|
2021
Q3 | – | Sell |
-119,445
| Closed | -$7.55M | – | 133 |
|
|
2021
Q2 | $7.55M | Buy |
+119,445
| New | +$7.55M | 0.93% | 40 |
|
|
2021
Q1 | – | Sell |
-134,945
| Closed | -$7.72M | – | 128 |
|
|
2020
Q4 | $7.72M | Buy |
+134,945
| New | +$7.72M | 1.07% | 38 |
|
|
2020
Q2 | – | Sell |
-28,350
| Closed | -$759K | – | 119 |
|
|
2020
Q1 | $759K | Buy |
+28,350
| New | +$759K | 0.25% | 96 |
|